Journal of Biological Chemistry
Volume 287, Issue 40, 28 September 2012, Pages 33781-33795
Journal home page for Journal of Biological Chemistry

Enzymology
Fibrils Colocalize Caspase-3 with Procaspase-3 to Foster Maturation*

https://doi.org/10.1074/jbc.M112.386128Get rights and content
Under a Creative Commons license
open access

Most proteases are expressed as inactive precursors, or zymogens, that become activated by limited proteolysis. We previously identified a small molecule, termed 1541, that dramatically promotes the maturation of the zymogen, procaspase-3, to its mature form, caspase-3. Surprisingly, compound 1541 self-assembles into nanofibrils, and localization of procaspase-3 to the fibrils promotes activation. Here, we interrogate the biochemical mechanism of procaspase-3 activation on 1541 fibrils in addition to proteogenic amyloid-β(1–40) fibrils. In contrast to previous reports, we find no evidence that procaspase-3 alone is capable of self-activation, consistent with its fate-determining role in executing apoptosis. In fact, mature caspase-3 is >107-fold more active than procaspase-3, making this proenzyme a remarkably inactive zymogen. However, we also show that fibril-induced colocalization of trace amounts of caspase-3 or other initiator proteases with procaspase-3 dramatically stimulates maturation of the proenzyme in vitro. Thus, similar to known cellular signaling complexes, these synthetic or natural fibrils can serve as platforms to concentrate procaspase-3 for trans-activation by upstream proteases.

Caspase
Drug Discovery
Enzyme Mechanisms
Kinetics
Protease
Fibrils
Procaspase
Zymogen

Cited by (0)

*

This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA136779, Grant F32 CA119641-03 from NCI (to D. W. W.), and Grant F32 AI077177 (to N. J. A.). This work was also supported by an Achievement Rewards for College Scientists (ARCS) Foundation Award (to J. A. Z.), a Scleroderma Research Foundation Evnin-Wright Fellowship (to J. A. Z.), and the Multiple Myeloma Translational Initiative (MMTI) at UCSF.

1

Present address: Dept. of Molecular and Experimental Medicine, Scripps Research Institute, La, Jolla, CA 92037.

2

Present address: Dept. of Biocatalyst Characterization and Design, Codexis Inc., 200 Penobscot Dr., Redwood City, CA 94063-4718.